← Leaderboards
Mark E Burkard
University Of Wisconsin-Madison
$10,864,762
Attributed
$14,670,734
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.3M · FY2011–25$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,408,455 · 10
By mechanism
P30$6,764,503 · 3
R01$6,070,497 · 4
T32$4,037,438 · 2
TL1$3,536,017 · 1
Top collaborators
- Beth A Weaver7 shared
- M Elizabeth Meyerand3 shared
- Michelle Anne Chui1 shared
- Lauren A Trepanier1 shared
Most similar at University Of Wisconsin-Madison
Same institution · by research overlap
- Beth A Weaver$5,539,731
- Howard Bailey$12,079,664
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsInnovationAffectCellsTrainingChromosomesMemberMitoticMitosisCancer TherapyRecruitScientistLaboratoriesCancer PatientCareerUniversitiesMicrotubulesResearch PersonnelGrantResponseBaseMitotic SpindleEvaluationEnsure
Grant awards (36)
Cancer Center Support Grant$2,502,881
P30 · FY2025 · CA · contact PI
Mechanisms of paclitaxel sensitivity and resistance$559,860
R01 · FY2025 · CA
Cancer Center Support Grant$249,938
P30 · FY2025 · CA · contact PI
Developmental Funds$125,145
P30 · FY2025 · CA · contact PI
Leadership, Planning and Evaluation$125,144
P30 · FY2025 · CA · contact PI
Cancer Center Support Grant$2,502,881
P30 · FY2024 · CA · contact PI
Mechanisms of paclitaxel sensitivity and resistance$529,300
R01 · FY2024 · CA
Leadership, Planning and Evaluation$396,414
P30 · FY2024 · CA · contact PI
Developmental Funds$380,079
P30 · FY2024 · CA · contact PI
Preclinical models of serous endometrial cancer from diverse patient populations$194,375
P30 · FY2024 · CA · contact PI
Exploring m6A RNA Modification in HIV-associated Cancers in Aging Populations (HIV-Associated Cancers in Aging Populations)$187,785
P30 · FY2024 · CA · contact PI
Regional differences in guideline-concordant cancer care and outcomes among American Indian Alaska Native people$99,861
P30 · FY2024 · CA · contact PI
Integrated Training For Physician-Scientists$1,044,963
T32 · FY2023 · GM · contact PI
Impact of chromosomal instability on sensitivity to microtubule-targeting drugs in breast cancer$533,016
R01 · FY2023 · CA
Mechanisms of Plk1 at the mitotic centromere$305,672
R01 · FY2023 · GM · contact PI
Integrated Training For Physician-Scientists$1,026,651
T32 · FY2022 · GM · contact PI
Impact of chromosomal instability on sensitivity to microtubule-targeting drugs in breast cancer$533,016
R01 · FY2022 · CA
Mechanisms of Plk1 at the mitotic centromere$305,672
R01 · FY2022 · GM · contact PI
Integrated Training For Physician-Scientists$57,036
T32 · FY2022 · GM · contact PI
Integrated Training For Physician-Scientists$967,732
T32 · FY2021 · GM · contact PI
Impact of chromosomal instability on sensitivity to microtubule-targeting drugs in breast cancer$542,912
R01 · FY2021 · CA
Mechanisms of Plk1 at the mitotic centromere$305,434
R01 · FY2021 · GM · contact PI
Integrated Training For Physician-Scientists$107,526
T32 · FY2021 · GM · contact PI
NRSA Training Core$886,119
TL1 · FY2020 · TR · contact PI
Integrated Training For Physician-Scientists$781,330
T32 · FY2020 · GM · contact PI
Impact of chromosomal instability on sensitivity to microtubule-targeting drugs in breast cancer$542,209
R01 · FY2020 · CA
Integrated Training For Physician-Scientists$52,200
T32 · FY2020 · GM · contact PI
NRSA Training Core$884,800
TL1 · FY2019 · TR
Impact of chromosomal instability on sensitivity to microtubule-targeting drugs in breast cancer$540,241
R01 · FY2019 · CA
NRSA Training Core$884,800
TL1 · FY2018 · TR
NRSA Training Core$880,298
TL1 · FY2017 · TR
Separation of late mitotic functions of polo-like kinase 1 with chemical genetics$276,569
R01 · FY2015 · GM · contact PI
Separation of late mitotic functions of polo-like kinase 1 with chemical genetics$276,569
R01 · FY2014 · GM · contact PI
Separation of late mitotic functions of polo-like kinase 1 with chemical genetics$266,889
R01 · FY2013 · GM · contact PI
Separation of late mitotic functions of polo-like kinase 1 with chemical genetics$276,569
R01 · FY2012 · GM · contact PI
Separation of late mitotic functions of polo-like kinase 1 with chemical genetics$276,569
R01 · FY2011 · GM · contact PI